The Expression, Prognostic Value, and Immunological Correlation of MCEMP1 and its Potential Role in Gastric Cancer

Figure 1

MCEMP1 expression in human cancers. (a) The mRNA level of MCEMP1 in various types of cancer (Oncomine); (b) MCEMP1 expression in different cancer types based on the GTEx and TCGA database; (c) the expression of MCEMP1 was different between GC and normal gastric tissues from GTEx databases (Normal 210 patients, Tumor 414 patients) and (d) TCGA (Normal 32 patients, Tumor 375 patients); (e) expression of MCEMP1 in TCGA-paired gastric cancer and normal tissues (Normal 27 patients, Tumor 27 patients); (f) the aberrant expression of MCEMP1 is based on the GEO database (GSE54129, Normal 21 patients, Tumor 111 patients); (g) MCEMP1 expression in different T-staging patients (T1 : T2 : T3 : T4 = 19 : 80 : 168 : 100) and (h) in different M-staging patients (M0&Normal: M1 = 330 : 32) and (i) in different age patients (207 patients >65 y, 164 patients ≤65 y). , , .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)